Code | 46287 | ||||||||||
MA number | 58/0436/07-S | ||||||||||
Product Form: | tbl 50x4 mg /1,25 mg (OPA/Al/PVC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 14.11.2007 |
Pediatric warnings: | Yes |
PIL: | PIL_Co-Prenessa 4 mg/1,25 mg_02/2022.pdf |
SPC: | SPC_Co-Prenessa 4 mg/1,25 mg_02/2022.pdf |
Safety feature | Yes |
Data update: | 09.01.2018 |